Therefore, we proponed a more comprehensive analysis of longitudinal studies that should be conducted to associate CD45RA+/CD45RO+ and CCL20+/CCR6+ ‘immunoscore’ to CIN progression and validate its value as prognostic methods. Here, CCR6 is linked to cervical squamous intraepithelial neoplasia.